Clinical Trial Update: Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma

View source ↗

Summary

Completed clinical trial from National Children's Hospital, Vietnam evaluating bleomycin as an adjunct therapy for lymphangioma reports favorable outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioma
• Lymphatic Malformations

Drugs mentioned

• Bleomycin (bleomycin)

Snippet

Sponsor: National Children's Hospital, Vietnam | Conditions: Lymphangioma, Lymphatic Malformations | Status: COMPLETED